Saba Rouhani1, Rebecca Hamilton White2, Ju Nyeong Park2, Susan G Sherman2. 1. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, United States; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, United States. Electronic address: srouhan1@jh.edu. 2. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, United States.
Abstract
BACKGROUND: Overdose Prevention Sites (OPS) operate worldwide as spaces where people can consume previously purchased drugs under supervision, and are linked to reductions in HIV/HCV transmission and fatal overdoses. As the United States weighs their merits and legality, research is needed to estimate acceptability and use among populations at high risk for overdose. We examine willingness to use OPS among street-based female sex workers (FSW) with prevalent drug use and associated morbidities. METHODS: We describe self-reported willingness, barriers and conditions around use of a hypothetical OPS among 141 FSW engaged in active drug use in Baltimore City, and describe trends using Pearson's χ2 and Fisher's exact tests. RESULTS: Most women had history of overdose (55 %) and were likely to use OPS (77 %). Willingness was higher among women who: were sexual minorities (97 %;P=0.002),experienced homelessness (82 %;P=0.019), injected drugs (82 %;P=0.013), shared syringes (82 %;P=0.007), experienced sexual violence (92 %;P=0.045) or reported heroin use (83 %;P=0.039) in the past 3 months. Common anticipated barriers included transportation (45 %) and fear of arrest (41 %). CONCLUSIONS: This study highlights a population of uniquely high-risk women who would benefit from an OPS integrated with other services. Conditions and barriers discussed are informative for planning and implementation.
BACKGROUND: Overdose Prevention Sites (OPS) operate worldwide as spaces where people can consume previously purchased drugs under supervision, and are linked to reductions in HIV/HCV transmission and fatal overdoses. As the United States weighs their merits and legality, research is needed to estimate acceptability and use among populations at high risk for overdose. We examine willingness to use OPS among street-based female sex workers (FSW) with prevalent drug use and associated morbidities. METHODS: We describe self-reported willingness, barriers and conditions around use of a hypothetical OPS among 141 FSW engaged in active drug use in Baltimore City, and describe trends using Pearson's χ2 and Fisher's exact tests. RESULTS: Most women had history of overdose (55 %) and were likely to use OPS (77 %). Willingness was higher among women who: were sexual minorities (97 %;P=0.002),experienced homelessness (82 %;P=0.019), injected drugs (82 %;P=0.013), shared syringes (82 %;P=0.007), experienced sexual violence (92 %;P=0.045) or reported heroin use (83 %;P=0.039) in the past 3 months. Common anticipated barriers included transportation (45 %) and fear of arrest (41 %). CONCLUSIONS: This study highlights a population of uniquely high-risk women who would benefit from an OPS integrated with other services. Conditions and barriers discussed are informative for planning and implementation.
Authors: Ian McKnight; Ben Maas; Evan Wood; Mark W Tyndall; Will Small; Calvin Lai; Julio S G Montaner; Thomas Kerr Journal: Am J Drug Alcohol Abuse Date: 2007 Impact factor: 3.829
Authors: Charles W Hoge; Lyndon A Riviere; Joshua E Wilk; Richard K Herrell; Frank W Weathers Journal: Lancet Psychiatry Date: 2014-08-14 Impact factor: 27.083
Authors: Paula Braitstein; Kathy Li; Mark Tyndall; Patricia Spittal; Michael V O'Shaughnessy; Arn Schilder; Caitlin Johnston; Robert S Hogg; Martin T Schechter Journal: Soc Sci Med Date: 2003-08 Impact factor: 4.634
Authors: Susan G Sherman; Saba Rouhani; Rebecca Hamilton White; Noelle Weicker; Miles Morris; Kristin Schneider; Ju Nyeong Park; Colleen Barry Journal: J Urban Health Date: 2022-05-24 Impact factor: 5.801
Authors: Kristin E Schneider; Catherine Tomko; Danielle Friedman Nestadt; Bradley E Silberzahn; Rebecca Hamilton White; Susan G Sherman Journal: Int J Drug Policy Date: 2020-07-22